Appeals Court Affirms Lifetime Ban of 'Pharma Bro' Martin Shkreli from Drug Industry

John Pinto | 24 January 2024

A federal appeals court upheld a lifetime ban on "pharma bro" Martin Shkreli from the pharmaceutical industry. The unanimous decision also enforces a $64.6 million penalty for monopolistic practices related to the price hike of Daraprim. The ban stems from a civil lawsuit by the Federal Trade Commission and seven states, including New York and California.